Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2006-11-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2006.091116PMID 17119008PMCID PMC2077656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stiff man syndrome: Clinical and laboratory findings in eight patients

  2004cited by this paper
• Mechanisms underlying cerebellar motor deficits due to mGluR1‐autoantibodies

  2003cited by this paper
• Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase.

  2003cited by this paper
• Glutamic acid decarboxylase autoantibodies and neurological disorders

  2002cited by this paper
• Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity

  2002cited by this paper
• Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies.

  2002cited by this paper
• Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

  2001cited by this paper
• Stiff person syndrome: Advances in pathogenesis and therapeutic interventions

  2001cited by this paper
• Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.

  2000cited by this paper
• Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase

  1999cited by this paper
• Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells.

  1997cited by this paper
• Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity

  1997cited by this paper
• Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration

  1996cited by this paper
• Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells.

  1985cited by this paper

• Gestational and Lactation Exposure to Perfluorohexanoic Acid Results in Sex-Specific Changes in the Cerebellum in Mice

  2025cites this paper
• A candidate projective neuron type of the cerebellar cortex: the synarmotic neuron

  2024cites this paper
• Anti-glutamic acid decarboxylase antibodies-associated cerebellar ataxia: A treatable ataxia

  2024cites this paper
• The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy

  2023cites this paper
• Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies

  2022cites this paper
• Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders

  2022cites this paper
• Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex

  2022cites this paper
• Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses

  2022cites this paper
• Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies

  2022cites this paper
• A Breakdown of Immune Tolerance in the Cerebellum

  2022cites this paper
• GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions

  2021cites this paper
• Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders

  2021cites this paper
• Endocrine Disorders

  2021cites this paper
• Reproducing Human Motor Adaptation in Spiking Neural Simulation and known Synaptic Learning Rules

  2021cites this paper
• A comparison of glutamic acid decarboxylase serum autoantibody levels in pediatric intractable and non-intractable epilepsy

  2021cites this paper
• Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.

  2021cites this paper
• Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias

  2020cites this paper
• Neurological Syndromes Associated with Anti-GAD Antibodies

  2020cites this paper
• GAD antibodies in neurological disorders — insights and challenges

  2020cites this paper
• Myoclonus-dystonia and cerebellar ataxia in association with anti-glutamic acid decarboxylase autoimmunity

  2020cites this paper
• Myoclonus-dystonia and cerebellar ataxia in association with anti-glutamic acid decarboxylase autoimmunity.

  2020cites this paper
• The neurological syndromes associated with glutamic acid decarboxylase antibodies.

  2019cites this paper
• Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.

  2019cites this paper
• Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.

  2018cites this paper
• Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia.

  2018cites this paper
• Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges

  2018cites this paper
• GABA and Glutamate: Their Transmitter Role in the CNS and Pancreatic Islets

  2018influential citation
• EXPLORING THE CLINICAL SPECTRUM OF GLUTAMIC ACID DECARBOXYLASE ANTIBODIES IN NEUROLOGICAL PATIENTS, THROUGH THE VALIDATION OF AN ENZYME-LINKED IMMUNOSORBENT ASSAY

  2018cites this paper
• Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.

  2017cites this paper
• Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome

  2017cites this paper
• Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias

  2017cites this paper
• Immune-mediated cerebellar ataxias: from bench to bedside

  2017cites this paper
• Neurologic Manifestations of Systemic Disease ( N Scolding , C Rice and A Wilkins

  2017cites this paper
• Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review

  2017cites this paper
• Aleteo diafragmático. Descripción de caso y revisión de la literatura

  2016cites this paper
• Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias

  2015cites this paper
• Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity

  2015cites this paper
• [Clinical characteristics of four patients with temporal lobe epilepsy associated with elevated anti-GAD antibodies].

  2015cites this paper
• Glycine receptor antibodies and progressive encephalomyelitis with rigidity and myoclonus with predominant motor neuron degeneration--Expanding the clinical spectrum.

  2015cites this paper
• Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

  2015cites this paper
• Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

  2015cites this paper
• Neuro-ophthalmic manifestations of cerebellar disease.

  2014cites this paper
• Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase.

  2014cites this paper
• Genetics of essential tremor: from phenotype to genes, insights from both human and mouse studies.

  2014cites this paper
• Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

  2014cites this paper
• Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats

  2013cites this paper
• Bergmann glia are reduced in spinocerebellar ataxia type 1

  2013cites this paper
• Intravenous Immunoglobulin and Rituximab for Cerebellar Ataxia with Glutamic Acid Decarboxylase Autoantibodies

  2013cites this paper
• Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice.

  2013cites this paper
• GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies

  2013cites this paper
• Essential tremor is not a neurodegenerative disease PERSPECTIVE

  2012cites this paper
• Essential tremor is not a neurodegenerative disease.

  2012cites this paper
• Stiff Person Syndrome and Other Anti-GAD–Associated Neurologic Disorders

  2012cites this paper
• Significance of cerebellar Purkinje cell loss to pathogenesis of essential tremor.

  2011cites this paper
• Cerebellar Purkinje cell loss is not pathognomonic of essential tremor.

  2011cites this paper
• Selective loss of Purkinje cells in a patient with anti-gliadin-antibody-positive autoimmune cerebellar ataxia

  2011cites this paper
• Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia

  2011cites this paper
• c‐Jun is essential for the induction of Il‐1β gene expression in in vitro activated Bergmann glial cells

  2011cites this paper
• Stiff person syndrome and cerebellar ataxia associated with glutamic acid decarboxylase antibodies and type 1 diabetes: What is the link between neurological diseases and autoimmunity to the beta cell?

  2010cites this paper
• Le syndrome de l’homme raide et autres maladies neurologiques associées aux anticorps anti-GAD

  2010cites this paper
• Effects of the glutamic acid decarboxylase (GAD) inhibitor semicarbazide and anti-GAD autoantibodies-containing immunoglobulin G on neuronal network activity within the motor cortex

  2010cites this paper
• Classification of cerebellar atrophy using voxel-based morphometry and SPECT with an easy Z-score imaging system.

  2010cites this paper
• [Stiff-person syndrome and other neurological disorders associated with anti-GAD antibodies].

  2010cites this paper
• Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.

  2010cites this paper
• Encephalitis and epilepsy

  2009cites this paper
• Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.

  2009cites this paper
• Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.

  2008cites this paper
• CLASSIC ESSENTIAL TREMOR CHANGES FOLLOWING CEREBELLAR HEMORRHAGE

  2008cites this paper
• Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.

  2008cites this paper
• Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

  2008influential citation
• CEREBELLAR HEMORRHAGE CLASSIC ESSENTIAL TREMOR CHANGES FOLLOWING

  2008cites this paper
• EFFECTS OF ANTI-GAD ANTIBODIES ASSOCIATED WITH NEUROLOGICAL DISEASES

  2007cites this paper
• Effects of anti–glutamic acid decarboxylase antibodies associated with neurological diseases

  2007cites this paper